H. Kotanides

发表

Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase*

Jacques Landry, Johannes Waltenberger, J. Landry, 2000, The Journal of Biological Chemistry.

Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

J. Haidar, M. Kalos, S. Eastman, 2020, Cancer Immunology Research.

Advances in Brief Inhibition of Vascular Endothelial Growth Factor-induced Receptor Activation with Anti-Kinase Insert Domain-containing Receptor Single-Chain Antibodies from a Phage Display Library

Zhenping, Zhen-ping, Zhu, 2006 .

Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2.

P. Bohlen, K. Persaud, Z. Zhu, 1999, Journal of immunological methods.

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.

D. Hicklin, P. Bohlen, X. Jimenez, 1999, Cancer letters.

Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

J. Haidar, M. Kalos, Leyi Shen, 2020, Molecular Cancer Therapeutics.

Paraneoplastic cerebellar degeneration: I. A clinical analysis of 55 anti-Yo antibody-positive patients

M. Rosenblum, J. Posner, H. Kotanides, 2011, Neurology.

Interleukin-4-induced STAT6 Recognizes and Activates a Target Site in the Promoter of the Interleukin-4 Receptor Gene*

N. Reich, H. Kotanides, Helen Kotanides, 1996, The Journal of Biological Chemistry.

Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.

D. Hicklin, P. Bohlen, Z. Zhu, 1998, Cancer research.

Novel therapeutic approach for neurogenic erectile dysfunction: effect of neurotrophic tyrosine kinase receptor type 1 monoclonal antibody.

G. Lin, T. Lue, Ching‐Shwun Lin, 2015, European urology.

A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth

K. Persaud, K. Paz, K. Credille, 2014, Cancer biology & therapy.

Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4.

N. Reich, H. Kotanides, Helen Kotanides, 1993, Science.

Characterization of the Interleukin-4 Nuclear Activated Factor/STAT and Its Activation Independent of the Insulin Receptor Substrate Proteins (*)

M. White, N. Reich, H. Kotanides, 1995, The Journal of Biological Chemistry.

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

D. Hicklin, Zhen-ping Zhu, B. Pytowski, 1998, Cancer and Metastasis Reviews.

DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity

D. Ludwig, Larry Witte, Dale L Ludwig, 2004, Oncogene.

Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene.

P. Bohlen, D. Ludwig, L. Witte, 2001, Gene.

Paraneoplastic cerebellar degeneration.

M. Rosenblum, J. Posner, H. Kotanides, 1992, Neurology.

Paraneoplastic cerebellar degeneration

M. Rosenblum, J. Posner, H. Kotanides, 1992, Neurology.